GILD
Gilead Sciences Inc
151.40$
-0.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.4% | -9.4% | -4.8% | +1.8% | +8.2% | -4.3% | -1.3% | +5.0% | +0.8% | -4.7% | -12.3% | |
| – | +0.7% | -12.7% | -12.3% | +20.0% | +29.7% | -11.8% | -12.9% | +21.4% | +2.6% | +1.6% | -25.2% | |
| – | +6.7% | -22.5% | -41.2% | +81.7% | +98.4% | -20.7% | -35.1% | +42.5% | +3.2% | +0.8% | -58.3% | |
| – | +21.6% | -27.4% | -30.7% | +59.5% | +72.7% | -31.5% | -34.2% | +41.0% | +30.8% | -20.5% | -58.4% | |
| – | -2.7% | +0.2% | -0.1% | -1.6% | -3.6% | -0.7% | +9.0% | +6.6% | -3.6% | -3.5% | +6.6% | |
| – | +7.5% | +3.7% | +9.3% | -7.7% | -8.5% | +2.9% | +3.8% | -2.2% | -0.6% | +7.9% | +2.0% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -2.6% | -11.4% | -2.5% | -10.0% | -2.9% | -3.0% | -4.1% | -3.2% | -5.5% | -3.5% | -14.3% | |
| – | -1.9% | -1.4% | -8.9% | +2.1% | +10.0% | -6.0% | -3.3% | +2.6% | -1.8% | -9.8% | +14.5% | |
| – | -5.6% | +15.4% | -17.2% | +8.8% | +2.4% | +2.8% | -9.3% | +9.9% | -3.9% | -19.8% | +16.3% | |
| – | +7.3% | +90.7% | -50.6% | +0.1% | +6.4% | +45.5% | +0.0% | +0.0% | +0.0% | -53.2% | +83.9% | |
| – | -6.1% | +13.1% | -13.7% | +68.2% | -7.8% | -11.5% | -21.0% | +38.8% | -11.5% | -9.8% | +4.5% | |
| – | +0.0% | -7.2% | +0.1% | -0.5% | +16.1% | -11.0% | 0.0% | 0.0% | 0.0% | -5.7% | +14.2% | |
| – | +2.3% | -23.2% | +4.2% | +1.1% | +4.6% | -0.9% | +2.7% | +9.5% | +5.4% | +3.6% | -49.7% | |
| – | +1.9% | -34.6% | +4.8% | -0.8% | +3.8% | -4.9% | +3.6% | +13.2% | +7.1% | +2.9% | -84.4% | |
| – | -0.1% | -0.7% | +0.3% | +0.2% | +0.4% | +0.0% | -0.3% | -0.1% | -0.1% | +0.1% | -0.9% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.